• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Highly conserved influenza A virus epitope sequences as candidates of H3N2 flu vaccine targets

tetano

Editor, Senior Moderator
Genomics. 2012 Jun 12. [Epub ahead of print]
Highly conserved influenza A virus epitope sequences as candidates of H3N2 flu vaccine targets.
Wu KW, Chien CY, Li SW, King CC, Chang CH.
Source

Institute of BioMedical Informatics, National Yang-Ming University, Taipei, Taiwan.
Abstract

This study focused on identifying the conserved epitopes in a single subtype A (H3N2)-as candidates for vaccine targets. We identified a total of 32 conserved epitopes in four viral proteins [22 HA, 4PB1, 3 NA, 3 NP]. Evaluation of conserved epitopes in coverage during 1968-2010 revealed that (1) 12 HA conserved epitopes were highly present in the circulating viruses; (2) the remaining 10 HA conserved epitopes appeared with lower percentage but a significantly increasing trend after 1989 [p<0.001]; and (3) the conserved epitopes in NA, NP and PB1 are also highly frequent in wild-type viruses. These conserved epitopes also covered an extremely high percentage of the 16 vaccine strains during the 42year period. The identification of highly conserved epitopes using our approach can also be applied to develop broad-spectrum vaccines.

Copyright ? 2012. Published by Elsevier Inc.

PMID:
22698979
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22698979
 
Back
Top Bottom